JUL 30, 2009
Three patients with inflamed or residual ptyerygia unresponsive to other therapy were each treated with a single subconjunctival Avastin or Lucentis injection. After one week, regression of conjunctival microvessels in the pterygial bed was seen in all cases. No side effects were noted during follow-up ranging from one to 13 months. The author concluded that selective blockade of vascular endothelial growth factor was effective at causing conjunctival microvessel regression.
Dr.Haas has no financial interests to disclose.